BRIEF-Galapagos gets orphan drug designation in EU for GLPG1690 in idiopathic pulmonary fibrosis

* Orphan drug designation in European Union for GLPG1690 in

idiopathic pulmonary fibrosis

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom:)

Read more